Skip Navigation

European Heart Journal 2002 23(4):263-264; doi:10.1053/euhj.2001.2913
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saikku, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saikku, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Seroepidemiology in Chlamydia pneumoniae — atherosclerosis association

P. Saikku

Department of Medical Microbiology, University of Oulu, Oulu, Finland

References

  1. Saikku P, Leinonen M, Mattila K. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;ii:983–985
  2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436[CrossRef][Web of Science][Medline]
  3. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. South African Med J. 1992;82:158–160
  4. Taylor-Robinson D. Chlamydia pneumoniae in vascular tissue. Atherosclerosis. 1998;140:S21–S24
  5. Halme S, Hertzen von L, Bloigu A. Chlamydia pneumoniae-specific cell-mediated and humoral immunity in healthy people. Scand J Immunol. 1998;47:517–520[CrossRef][Web of Science][Medline]
  6. Karvonen M, Tuomilehto J, Pitkäniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987. Epidemiol Infect. 1993;110:349–360[Medline]
  7. Leinonen M, Linnanmäki E, Mattila K. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microbial Pathogenesis. 1990;9:67–73[CrossRef][Web of Science][Medline]
  8. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol. 1993;31:2212–2214[Abstract/Free Full Text]
  9. Tavendale R, Parratt D, Pringle SD, A’Brook R, Tunstall-Pedoe H. Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events; the Scottish Heart Health Study Cohort. Eur Heart J. 2002;23:301–307[Abstract/Free Full Text]
  10. Peeling RW, Wang S-P, Grayston JT. Chlamydia pneumoniae serology: Interlaboratory variation in microimmuno-fluorescence assay results. J Infect Dis. 2000;181:S426–429
  11. Saikku P, Leinonen M, Tenkanen L. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med. 1992;116:273–278[Abstract/Free Full Text]
  12. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87:1130–1134[Abstract/Free Full Text]
  13. Apfalter P, Blasi F, Boman J. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol. 2001;39:519–524[Abstract/Free Full Text]
  14. Roivainen M, Viik-Kajander M, Palosuo T. Infections, inflammation, and the risk of coronary heart disease. Circulation. 2000;101:252–257[Abstract/Free Full Text]
  15. Kiechl S, Egger G, Mayr M. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation. 2001;103:1064–1070[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Griffiths, A. Bakhai, D. West, M. Petrou, T. De Souza, N. Moat, J. Pepper, and C. Di Mario
Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease
Eur. J. Cardiothorac. Surg., September 1, 2004; 26(3): 528 - 534.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saikku, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saikku, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?